Markers of Immune Activation and Inflammation in Individuals With Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection.
Saved in:
| Title: | Markers of Immune Activation and Inflammation in Individuals With Postacute Sequelae of Severe Acute Respiratory Syndrome Coronavirus 2 Infection. |
|---|---|
| Authors: | Peluso MJ; Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, California, USA., Lu S; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA., Tang AF; Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, California, USA., Durstenfeld MS; Division of Cardiology, University of California, San Francisco, San Francisco, California, USA., Ho HE; Icahn School of Medicine at Mount Sinai, New York, New York, USA., Goldberg SA; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA., Forman CA; Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, California, USA., Munter SE; Division of Experimental Medicine, University of California, San Francisco, San Francisco, California, USA., Hoh R; Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, California, USA., Tai V; Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, California, USA., Chenna A; Monogram Biosciences Inc, South San Francisco, California, USA., Yee BC; Monogram Biosciences Inc, South San Francisco, California, USA., Winslow JW; Monogram Biosciences Inc, South San Francisco, California, USA., Petropoulos CJ; Monogram Biosciences Inc, South San Francisco, California, USA., Greenhouse B; Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, California, USA., Hunt PW; Division of Experimental Medicine, University of California, San Francisco, San Francisco, California, USA., Hsue PY; Division of Cardiology, University of California, San Francisco, San Francisco, California, USA., Martin JN; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA., Daniel Kelly J; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA., Glidden DV; Department of Epidemiology and Biostatistics, University of California, San Francisco, San Francisco, California, USA., Deeks SG; Division of HIV, Infectious Diseases, and Global Medicine, University of California, San Francisco, San Francisco, California, USA., Henrich TJ; Division of Experimental Medicine, University of California, San Francisco, San Francisco, California, USA. |
| Source: | The Journal of infectious diseases [J Infect Dis] 2021 Dec 01; Vol. 224 (11), pp. 1839-1848. |
| Publication Type: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Oxford University Press Country of Publication: United States NLM ID: 0413675 Publication Model: Print Cited Medium: Internet ISSN: 1537-6613 (Electronic) Linking ISSN: 00221899 NLM ISO Abbreviation: J Infect Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1537-6613 |
|---|---|
| DOI: | 10.1093/infdis/jiab490 |
